Programmable bacterial catalysis – designing cells for biosynthesis of value-added compounds  by Lam, Carolyn M.C. et al.
FEBS Letters 586 (2012) 2184–2190journal homepage: www.FEBSLetters .orgReview
Programmable bacterial catalysis – designing cells for biosynthesis
of value-added compounds
Carolyn M.C. Lam a,b,1, María Suárez Diez b, Miguel Godinho a,c, Vítor A.P. Martins dos Santos b,⇑
a Systems and Synthetic Biology Group, Helmholtz Centre for Infection Research, Inhoffenstraße 7, D-38124 Braunschweig, Germany
b Systems and Synthetic Biology, Wageningen University, Dreijenplein 10, Building number 316, 6703 HB Wageningen, The Netherlands
c Lifewizz Lda, Rua Pero de Alenquer 123 7 E, 4150-616 Porto, Portugal
a r t i c l e i n f oOpen access under CC BY-NC-ND license.Article history:
Received 15 January 2012
Revised 16 February 2012
Accepted 20 February 2012
Available online 25 February 2012
Edited by Thomas Reiss and Wilhelm Just
Keywords:
Gene circuits
Chassis
Genome-scale modelling
Pseudomonas putida
Synthetic biology0014-5793  2012 Published by Elsevier B.V. on beh
doi:10.1016/j.febslet.2012.02.030
⇑ Corresponding author.
E-mail address: vitor.martinsdossantos@wur.nl (V
1 Current address: Systems and Synthetic Biology,
jenplein 10, Building number 316, 6703 HB Wageninga b s t r a c t
Bacteria have long been used for the synthesis of a wide range of useful proteins and compounds.
The developments of new bioprocesses and improvements of existing strategies for syntheses of
valuable products in various bacterial cell hosts have their own challenges and limitations. The ﬁeld
of synthetic biology has combined knowledge from different science and engineering disciplines
and facilitated the advancement of novel biological components which has inspired the design of
targeted biosynthesis. Here we discuss recent advances in synthetic biology with relevance to bio-
synthesis in bacteria and the applications of computational algorithms and tools for manipulation
of cellular components. Continuous improvements are necessary to keep up with increasing
demands in terms of complexity, scale, and predictability of biosynthesis products.
 2012 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction
The natural abilities of many bacteria are highly exploitable for
production processes to make food, medicines, and plenty of other
useful compounds. As technology advanced, new applications of
micro-organisms have been developed to synthesize enzymes for
various catalysis, biofuels from alternative raw materials, artiﬁcial
molecules such as drugs and biodegradable polymers, and to
metabolize harmful environmental pollutants. Traditional cell
engineering is a species-dependent task since the microbiological
and genetic tools applicable to one type of cells are often dysfunc-
tional or sub-optimal in another cell host. Therefore, it is desirable
to have standardized methodologies to forward engineer suitable
metabolic responses and capabilities across a wide range of spe-
cies. With an increasing amount of knowledge of bacteria stem-
ming from systems biology as well as other disciplines including
molecular biology, genetics, bioinformatics, biochemistry, engi-
neering, and computational simulation, the ﬁeld synthetic biology
has assembled all relevant expertise and facilitated the develop-
ment of artiﬁcial biological parts and functions to serve numerous
purposes. There is much potential in the solutions that can bealf of the Federation of European B
.A.P. Martins dos Santos).
Wageningen University, Drei-
en, The Netherlands.found to solve some of the current challenges in cell culture
processes regarding productivity, lack of suitable enzymes or
metabolic pathways, and limitations from existing cell hosts. But
much research is still needed to further understand the interac-
tions among natural cellular components and artiﬁcial elements
as well as develop appropriate computational methods for integra-
tion of the characterization, analysis, and design of biological parts
to increase efﬁciency.
2. Cell hosts for biosynthesis
Owing to their outstanding versatility, bacteria are common and
preferred hosts for synthesis of a wide range of chemicals and bio-
logical compounds. Enzymatic catalysis for production of target
compounds is an attractive method especially when the structure
of the product molecule is complex. Despite a long history of appli-
cation in the industry with continuous process improvement to en-
hance product yields and qualities, there are stillmany challenges to
be overcome. For example, there are general issues with low prod-
uct yield, slow growth, and missing pathways for speciﬁc value-
added compounds. For Escherichia coli, one of the commonly used
bacterial strains, the post-transcriptional modiﬁcation capability
andmetabolic capacity is limited that only a narrow range of natural
proteins and compounds can be synthesized [1]. The protein
products in E. coli sometimes are secreted into the periplasm or
form inclusion bodies, which increase the difﬁculty for productiochemical Societies. Open access under CC BY-NC-ND license.
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bacterium contains an endotoxin lipopolysaccharide (LPS) which, if
not completely removed in puriﬁcation of proteins for clinical pur-
poses, causes fever in humans [4]. Bacillus subtilis is another popular
bacterial strain for protein syntheses which is endotoxin-free and
has high capacity of protein secretion into extracellular medium
[5] but there are certain bottlenecks such as insufﬁcient suitable
expression vectors, plasmid instability, misassembled proteins,
intracellular insoluble aggregates of heterologous proteins, and pro-
tein degradation by proteases that need to be addressed [6–8]. An
illustration of these limitations is shown in Fig. 1. Some of the chal-
lenges are tackled by over-expression of molecular chaperones to
reduce intracellular heterologous protein aggregates [6], protease
gene knock-out to reduce product degradation [8], engineering of
metabolic pathways [9] or membrane-bound enzymes [10] that af-
fect product synthesis, or selecting a different cell host such as the
use of Thermus thermophilus for production of thermophilic proteins
which cannot be synthesized in E. coli [11], and the use of Pseudomo-
nas putida for its resistance to toxic aromatic compounds [12–14].
But new cell host candidates are relatively less characterized and
require adaptation of cell engineering techniques from other
micro-organisms. As the synthesis bottlenecks are also pathway-
dependent, there is no single optimal strategy for all bacterial sys-
tems. Cell engineering for biosynthesis would beneﬁt from a more
systematic approach of designing cellular responses, developing
suitable cell hosts, creating new metabolic pathways, and adding
novel artiﬁcial functions to the biological system.mis-folded 
protein
plasm
instab
protease
limited appropriat
expression vector
insoluble protein 
aggregate
low product 
yield
missing 
pathway
...
AAA
Fig. 1. Illustration of limitations for synthesis of foreign proteins or molecules due to low
limited post-transcriptional modiﬁcation capability, protein products being secreted into
suitable expression vectors, plasmid instability, misassembled proteins, intracellular inso
common bacterial hosts.3. An ideal chassis for bioprocesses
Genes with unknown functions are commonplace in the se-
quenced genomes of many bacteria. Redundancy in genomes often
poses additional challenge in predicting the behaviors of synthetic
parts in the cellular system since unexpected interactions can arise.
An ideal candidate for biosynthesis programming would be a well-
characterized micro-environment containing only the necessary
functions to synthesize the product of interest. Such a chassis, that
can satisfy the production requirements of a bioprocess, may take
the form of a simpliﬁed living cell, or alternatively an artiﬁcial envi-
ronment capable of biosynthesis but unable to grow. The search for
a standardized host in synthetic biology has been divided into the
bottom-up versus top-down approaches. The bottom-up approach
focuses on creating a protocell using deﬁned components. Lipids
have been used to form bilayer vesicles [15] encapsulating genetic
information and transcriptional/translationalmachinery for protein
synthesis [16]; and lipid vesicles retaining genetic materials have
been shown to be thermostable at various temperature [17]. After
about a decade’s investigation of RNA and DNA replication and pro-
tein expression in protocells, latelymore research have dedicated to
the in silico understanding of the properties of lipid vesicles, laying
down further necessary knowledge for engineering protocells. Sto-
chastic analysis of a minimal cell model, known as a chemoton,
resembling a protocell suggested convergence of the cell division
time to a stable value [18]; and competing template replications
can coexist when there is coupling between their reactions [19].toxin
inclusion 
bodies
protein in 
periplasm
id 
ility
e 
s
slow growth
limited post-transcriptional 
modification capability
AA
product yield, slow growth, missing pathways for speciﬁc value-added compounds,
periplasm or form inclusion bodies, endotoxin lipopolysaccharide (LPS), insufﬁcient
luble aggregates of heterologous proteins, and protein degradation by proteases in
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necessary for life. Thus, in the top-down approach redundant genes
inmicro-organisms are identiﬁed and removed to generatemutants
with smaller genomes. Several experimental genomeminimization
studies have reduced the genomes of a few bacteria by different ex-
tent, such as a recent study of the human and amoeba pathogen
Legionella pneumophila Philadelphia 1 which have led to a strain
with 18.5% of the original 3.4 Mbp genome removed, but nonethe-
less it is able to grow on bacteriological culture [20]; an improve-
ment in expression of recombinant enzymes in a mutant of B.
subtilis strain 168 with 20.7% of the 4.2 Mbp genome removed
[21]; and a reduction of the 6.2 Mbp genome of the versatile soil
bacterium P. putida by 7.4% [22]. Progresses in gene deletion tools,
including recent examples of a vector platform developed byMartí-
nez-García and de Lorenzo which allows precise and accumulative
gene deletion in a wide range of Gram-negative bacteria with suc-
cessful application to study the multi-resistant antibiotic proﬁle of
P. putida [23] and amethod based on the Flp-FRT recombination sys-
tem and minitransposon which enables rapid random large-scale
genomic deletion [24], have signiﬁcantly increased the efﬁciency
in genomeminimization. From the trend that protocells are gaining
capability in handling biochemical processes with increasing com-
plexity, and genomes of bacteria are being reduced to simplify the
metabolic system, it is conceivable that both approaches can pro-
vide candidates with high applicability in synthetic biology
(Fig. 2). A construct, or a chassis, which can provide an optimal
and robust environment to host synthetic circuitries to support
any desirable biosynthetic processes will be a very valuable tool
for implementing synthetic cellular functions. The bottom-up
approach delivers protocells that are becomingmore usable for pro-
duction of proteins, enzymes, and complex molecules as the num-
ber of basic functions related to self-maintenance and synthesis/
transportation of the target molecules is increased (Fig. 2).
Protocells have the advantage of simplicity in structure, which is
attractive for biosynthesis of simple molecules. But the addition of
functions to protocell is likely to reach a plateau eventually as a re-
sult of highmarginal costs over further increase in functionality. On
the other hand, as the genome of a living cell is continuously re-
duced, the degree of minimization is limited by the cardinality of
the smallest subset, or subsets, of geneswhich are required tomain-
tain a minimal living and reproducible cell under different nutrient
availability (Fig. 2). The relationship between genome size and
nutrient dependency can be seen from the reliance on amino acids,Complexity
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Fig. 2. Conceptual projection of the applicability of artiﬁcial cellular constructs
based on the bottom-up and top-down approaches as suitable chassis for
biosynthetic processes. Protocells and streamlined bacterial genomes are becoming
more useful for production of value-added compounds when the functionality of
protocells continues to grow and redundant genes in existing and new bacterial
hosts are gradually being removed. It is not clear what the maximum applicability
that can be reached by each of the approaches will be. In the ﬁgure both approaches
are shown to reach a similar maximum applicability to reﬂect the fact that most
likely each of the approaches will produce optimal chassis for different types of
process.purines, and pyrimidines from the surroundings for the symbiotic
Mycoplasma pneumoniaewith a 0.8 Mbp genomebut not for the cya-
nobacterium Prochlorococcus marinus which has a genome of
1.75 Mbp [25]. The minimum number of genes estimated to be
essential for cell growth is so far dependent on the organisms stud-
ied. Comparison between Mycoplasma genitalium and Haemophilus
inﬂuenzae suggested that 256 genes are close to theminimal to sup-
port a living cell [26] but 271 indispensable genes were identiﬁed
for B. subtilis [27]. It has also been proposed that 151 genes are suf-
ﬁcient to build a minimum cell [28]. Since analyses of sequenced
genomes revealed a lack of ubiquitous set of genes for core func-
tions, it is likely that there are orthologous genes sharing the same
cellular functions [29,30]. Overall, the chassis obtained from each
approach is likely to be suitable for speciﬁc types of bioprocess.
Since high-throughput techniques are starting to provide quantita-
tive data for the construction and validation of whole-systemmod-
els, such as the measurements of the transcriptome [31], proteome
[32], and metabolome [33] of M. pneumoniae, the development of
standardized chassis implies not only the availability of suitable
biological constructs to host the introduced circuits but also the in
silico construction of standard quantitative models which are able
to reproduce biological behaviors and predict new properties for
each of the chosen chassis.4. Designing biological circuits and metabolic pathways
Gene networks play an important role in determining the
behavior of a cell. The notions of logic gates and circuits have
gained popularity in describing gene networks since the former
allow engineering methodologies for systematic network design
to be conceptually transferred into biological systems. Most of
the biological circuits developed earlier in synthetic biology in-
volve DNA transcriptional control where activating or repressing
relationships are designed among transcription factors, inhibitors,
promoter, and upstream operator, producing transcription re-
sponses resembling Boolean logics and logic gates with AND, OR,
NOT, NAND, NOR, or more complex input–output relationships. It
has been demonstrated recently that the normal quorum sensing
mechanism in bacteria can be linked to a synthetic gene circuit
to stimulate over-expression of recombinant proteins under high
cell density [34]. E. coli continues to serve as a popular host for
new circuit applications, such as a synthetic modular electron
transfer circuit which facilitated hydrogen production [35], and a
synthetic reporter protein speciﬁc for copper ions has transformed
the bacterium into an automatic copper remover [36]. Other bacte-
rial hosts have gradually gained applicability in circuit design,
including a hybrid genetic circuit for investigating protein secre-
tion in Salmonella typhimurium SL1344 [37]; and the TOL circuit
in P. putida mt2 which has been modelled as a set of logic gates
to understand the growth patterns in mixed carbon sources
[38,39] and a metabolic ampliﬁer motif has been revealed from lo-
gic modelling of the circuit [40]. Circuits involving RNAs are also
becoming popular in synthetic bacterial circuits [41,42]. In recent
years, designs of genetic circuits have become automated using li-
braries of genetic elements [43] and rational approach for speciﬁed
circuit output properties without involving complex optimization
algorithms [44]. The design, analysis, and DNA sequence inference
of gene circuits have gained efﬁciency from a computer-aided cir-
cuit design tool [45,46] and an algorithm generating DNA sequence
from circuit connection [47]. As a large amount of artiﬁcial biolog-
ical circuits have been developed which can serve to construct a
wide range of input–output relationship, the need of standardiza-
tion to promote cross-applicability of the circuit parts is becoming
stronger. It is also important that the biological circuits are
well-characterized, particularly since there has not been a single
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adopted by most designed circuits. Unknown interaction between
synthetic biological circuit and host [48] and inﬂuence from intri-
cate parameters which are usually not considered in circuit design
and modelling often hamper the intended feature of the artiﬁcial
circuit. For example, a suicide circuit for E. coli induced unexpected
population oscillation due to unknown feedback between cell den-
sity and plasmid ampliﬁcation [49]. In some occasions, an exhaus-
tive analysis of the properties of the underlying cellular system is
required to explain, for instance, the ﬂuctuation of intracellular
protein concentration which can have subtle effect on exogenous
circuit. An example can be found from the interactions between
cell cycle and oscillations of cell volume and protein concentration
in yeast [50]. It is necessary to have the characteristics of synthetic
gene circuits structurally organised to facilitate a wide scope of
application.
Among the possible biological circuits that can be designed and
introduced into a cell host, those leading to the productions of
valuable molecules using the cellular machinery of the hosts are
highly relevant for improvement of existing bioprocesses. Natural
organisms evolve to adapt to the environment but their goals can
be far from optimizing metabolic pathways of industrial interest.
The ability to artiﬁcially design new enzymes and metabolic net-
works in a systematic way has revolutionized the manipulation
of metabolism in cells. Extensive computational analysis is gradu-
ally adopted into the design process of novel proteins. For example,
a multi-objective computational design approach is able to extend
protein promiscuity and to endow the thioredoxin from E. coliwith
a promiscuous esterase function while maintaining the native oxi-
doreductase activity [51]. For the production of compounds for
which no natural pathways have been elucidated, feasible solu-
tions can be predicted through a retro-biosynthetic approach sim-
ilar to the retro-synthesis method developed in organic chemistry
that the metabolic pathway leading to the synthesis of a target
compound is speciﬁed by considering the biotransformation of
functional groups rather than the entire structure, assuming the
availability of enzymes for the desired transformation. The retro-
biosynthetic approach may result in numerous candidate path-
ways which need to be further selected to identify the most prom-
ising option. Carbonell et al. and Cho et al. have proposed different
prioritizing strategies and tested them with the prediction of novel
biosynthesis pathways for isobutanol, 3-hydroxypropionate, bu-
tyryl-CoA [52], penicillin G, and cephalosporin [53] in E. coli. The
substrate promiscuity property of already known enzymes may
present a source for the required catalysts of retro-biosynthesis.
Advances in protein design also make this an increasingly likely
proposition [51,54]. Alternatively, utilizing enzymes directly from
other organisms offers operable results, such as the construction
of a synthetic pathway for the conversion of glucuronic acid to
glucaric acid from glucose in E. coli by assembling genes originally
from Saccharomyces cerevisiae, mice, and Pseudomonas syringae
[55]. Constructions of missing pathways in micro-organisms have
also been sped up by computational selection of enzyme-coding
genes from other species [56]. Computational prediction of new
protein interactions [57], and algorithmic creation of new enzymes
either by using pure computational tools [58] or by combining
these tools with in vitro directed evolution techniques [59] have
considerably increased the efﬁcacy of extracting correlations from
experimental data and screening feasible candidates for new met-
abolic pathway and protein structures to reduce the time and cost
of experimental trials. Traditional optimization of biological com-
ponents often involve directed evolution where experimental ran-
dom alterations create a library of variants which are then
screened for the required properties or further evolved under spe-
ciﬁc conditions to achieve target functions. But the accumulation
of experimental data has gradually enabled development of com-putational models and algorithms which represent known biolog-
ical interactions and can be used to discover hidden relationships
and novel system properties. Computational selection of the de-
signs of proteins, enzymes, and metabolic pathways is becoming
more indispensable and will continue to reduce experimentation
time as new experimental data are fed backwards into models
and algorithms to improve prediction accuracy (Fig. 3). Although
bioinformatics has already delivered a broad range of tools essen-
tial for the engineering of metabolic pathways, the collection of
computational tools that synthetic biology has at its disposal is still
fairly fragmented and lacks an integrative solution. As synthetic
biology matures, those computational tools need to be shaped
and aggregated in ways that permit a smooth workﬂow and, con-
sequently, higher efﬁciencies in bioprocess development.
Bacteria have been increasingly used to synthesize foreign com-
pounds and proteins, such as drug molecules, biofuel, and proteins
containing unnatural amino acids. Various terpenoid precursors
have been successfully synthesized in E. coli by, for example,
engineering the taxadiene metabolic pathway [60] or the deoxy-
xylulose 5-phosphate pathway [61], providing general platforms
to produce terpenoids with higher speciﬁc productivity than the
original plant sources. Bacteria are also used to synthesize other
valuable metabolites such as benzylisoquinoline alkaloids (BIAs)
which can be used for anti-cancer, anti-oxidative, and anti-HIV
therapeutics [62], and polyketides with antibiotic functions [63].
Much effort has also been put into synthesizing alkanols, biodiesel,
and hydrocarbons in E. coli [64–68]. An alkane synthesis pathway
in cyanobacteria has been shown to be transferrable into E. coli
[69], illustrating the possibility of expressing useful biofuel path-
ways in common cell hosts. Genome-scale metabolic models of
the cyanobacteria Arthrospira (Spirulina) maxima [70] and Synecho-
cystis [71,72] have been developed to ﬁnd conditions optimizing
hydrogen photoproduction. Comparison between genome-scale
metabolic models of various strains are often hindered by differ-
ences inherited from their distinct reconstruction methods, but re-
cently a metabolic network reconciliation process has been
proposed to identify true biological differences among metabolic
models of different strains [73]. Unnatural amino acids (UAAs)
have enabled anchoring additional functions onto protein, control-
ling substrate speciﬁcity of an enzyme [74], and signiﬁcant
enhancement of enzymatic activity [75]. Pairs of aminoacyl-tRNA
synthetase/tRNA from archaea were found to be orthogonal in
E. coli and increased the speciﬁcity of UAAs incorporation [76]. Bor-
rowing enzymes from other bacteria is an alternative for synthesis
of UAA, as in the example of L-homoalanine produced in E. coli by
incorporating enzymes from Bacillus and Streptomyces species [77].
A similar strategy has also been adopted to synthesize an effective
biosurfactant rhamnolipid in P. putida using enzymes originally
from pathogenic P. aeruginosa, resulting in high production yield
and better growth resistance against the antimicrobial effect of
the rhamnolipid than other bacteria such as E. coli or B. subtilis
[78]. But the design of effective metabolic pathways to produce
foreign compounds, including the utilization of artiﬁcial amino
acids to generate novel enzymes for new pathways, is relatively
less systematic than the development of biological circuit compo-
nents. Each type of cell host has its unique limitations and the
product structures also affect the synthesis bottlenecks, thus the
optimal metabolic adjustment for a new compound or a different
host is hard to be predicted in advance. The complexity, incom-
plete understanding of potential cell hosts, and limitation in the
natural cell machinery are hurdles to be overcome for the future
of bacterial biosynthesis. The demand of biosynthesis of valuable
materials and metabolites using bacteria, particularly for simpler
cell hosts to produce natural biological products or for robust hosts
to synthesize compounds and macromolecules, is growing ever
faster. Successful pathway designs have brought considerable
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Fig. 3. Trend of increasing involvement of computational analysis and optimization in the designs of synthetic biological circuit/metabolic pathway connectivity, protein
structure, DNA sequence, and other cellular parts which are involved in biosynthesis.
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materials, drugs, additives, and catalysts. Further improvement in
the prediction of cellular metabolic performance will speed up
the time required for searching new optimal pathways and
enhancing the property of novel molecules which are constantly
being designed or discovered to improve living standards.
5. Future perspectives
Bacterial systems are promising environments to deliver
biosynthesis of a large variety of products, from (semi-)bulk
compounds such as organic acids or precursors of bioplastics to
ﬁne chemicals and pharmaceuticals. Some applications have al-
ready found their ways into the production processes of valuable
compounds; and the control as well as detection of speciﬁc biolog-
ical or biochemical reactions have been demonstrated to be highly
tunable using synthetic circuits. From the current development of
logic gates in bacterial cells, it is foreseeable that gene circuits will
be able to selectively adjust or activate metabolic pathways in a ro-
bust manner to enable ﬂexible manipulation of biosynthesis. Well-
deﬁned and stable chassis in the form of streamlined bacteria or
protocells will provide more options for expression of novel or
foreign enzymatic routes, which can be pre-selected and optimizedthrough in silico analysis. Computational involvement in designing
synthetic biological processes will take a more signiﬁcant role
when the accuracy of predictions continues to be improved by re-
ﬁned knowledge of the biological system. A deeper understanding
of various bacterial hosts or other suitable chassis and a greater
capability to rationally design biological functions empowered by
synthetic biology will help to improve bio-industrial processes,
such as increasing enzyme activity, changing substrate speciﬁcities
of enzymes, using alternative hosts for biosynthesis, creating new
metabolic or transportation pathways, faster selection of enzymes
for tailor-made functions etc. Further integration between experi-
mentation and computational prediction and analysis is important
in order to harvest the synergy to efﬁciently gain accurate and de-
tailed knowledge of the cellular complexity which is still not
completely understood. Synthetic biology is ever more starkly
inﬂuencing the evolution of bioproduction processes. There are
still many challenges ahead, in particular for complex networks
or new cell hosts regarding the fact that a synthetic unit may not
function fully as predicted in the biological system. Further
investigations are necessary to search for appropriate solutions
to current bottlenecks and explore for more applications with the
synthetic biosynthesis capability of bacteria.
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